X-Mind® trium true low dose - Press release

29 Mar 2019
X-Mind® trium true low dose - Press release

X-MIND® trium: Finally a TRUE LOW DOSE 3D CBCT imaging system.


Premiering at IDS 2019, TRUE LOW DOSE is the latest X-MIND® trium CBCT innovation from ACTEON, with up to 50% less radiation exposure* and no loss of image quality and accuracy. This is possible thanks to new algorithm** associated with an innovative mechanism that brings the X-ray sensor and source closer to the patient. This results in increased protection for the patient, while preserving the most reliable and accurate diagnosis possible for the practitioner. This innovation confirms ACTEON’s leadership in the design of less invasive and less traumatic dental imaging technologies.



X-ray radiation reductions of up to 50%*

The new algorithm developed by ACTEON allows image acquisition with significantly reduced exposure time, resulting in a lower dose to the patient. The algorithm applied to these lower-dose projections improves contrast and decreases noise, thus accurately revealing the anatomical structures. This unprecedented patient protection is achieved without compromising image quality.


Greater child protection through increasingly less invasive innovative technologies

The new specific acquisition mode for smaller patients, and children in particular, reduces their radiation exposure. The X-ray sensor and source slide closer to the patient. In close proximity to the head, the unit emits less radiation while achieving image quality equivalent to standard acquisition.***

Pioneer on true innovation on the worldwide dental imaging market, ACTEON is maintaining and expanding its position with its TRUE LOW DOSE solution: facilitating procedures for the practitioner through features that are less traumatic and more acceptable for the patient.


Accurate diagnosis and planning for higher success rates

ACTEON's CBCT integrates high performance, state-of-the-art tools to increase diagnostic reliability and improve patient care. With X-Mind® trium and ACTEON® Imaging Suite software, treatment becomes more efficient and safer, less traumatic and therefore less stressful. Bone density around the implant is assessed with a single click, allowing easier clinical decision-making. Its simplified implant planning program generates complete reports in less than a minute.

X-Mind® trium has a small field of view (Ø40x40) and provides ultra high-resolution images (75 µm), making it the new reference in endodontics.

X-Mind® trium adapts to the growing needs of dental offices by pairing 2D panoramic with 3D imaging and digital cephalometric analysis when necessary. Cephalometric radiography offers simpler patient positioning and the smallest physical footprint on the market.

X-Mind® trium is the ultimate Mac-compatible therapeutic tool that adapts to the practitioner’s working environment.


* Ratio based on DAP measurements from standard X-Mind® trium settings: 90kV-8mA-300prjs

** Coming soon

*** Patent pending